Research Article
Volume 1 Issue 4 - 2017
Antibacterial Evaluation of Ethanolic Leaf Extract of Gongronema Latifolium Benth on MDR Bacteria from Clinical Specimens
1Faculty of Pharmaceutical Sciences Nnamdi Azikiwe University, Awka P.M.B 5025 Awka Anambra State Nigeria
2Department of Applied Microbiology, Ebonyi State University, P.M.B 053, Abakaliki Ebonyi State
2Department of Applied Microbiology, Ebonyi State University, P.M.B 053, Abakaliki Ebonyi State
*Corresponding Author: Malachy C Ugwu, Faculty of Pharmaceutical Sciences Nnamdi Azikiwe University, Awka P.M.B 5025 Awka Anambra State Nigeria.
Received: October 11, 2017; Published: October 31, 2017
Abstract
The rapid emergence of antibiotic resistance among hospital pathogens is a serious threat to the management of infectious diseases. The resistance problem demands that a renewed effort be made to seek effective antibacterial agents from bioactive phytochemicals of Plants. This study was carried out to evaluate the antibacterial activity of the ethanolic leaf extract of Gongronema latifolium on multidrug resistant clinical bacterial isolates. The antibacterial effects of ethanolic leaf extracts of G. Latifoliumwere evaluated by the agar well diffusion and micro broth dilution methods on multidrug resistant strains of E. coli, S. aureus, S. saprophyticus and K. pneumoniae isolated from tertiary hospital. Phytochemical screenings were also conducted on the G. Latifolium leaf extracts. Our study has shown high rate of resistance of E. coli, S. aureus, S. saprophyticus and K. pneumoniae isolates to somefrontline antibiotics.
The Phytochemical analysis revealed that G. Latifolium leaf contains alkaloids, tannins, saponnins, cardiac glycosides, flavonoids, steroids and protein and these phytoconstituents can be said to be responsible for the antibacterial activity of the plant. The extract showed good activity against the multiple drug resistant bacteria in order of K. pneumoniae > E. coli > S. aureus >and S. saprohyticus. The ethanolic leaf extract of G. latifoliumcan be effectively used in the eradication/treatment of clinical infections caused by the multiple drug resistance isolates of K. pneumoniae, E. coli, S. aureus and S. saprophyticus.
Keywords: Gongronema latifolium; MDR; Bacteria; clinical specimens; phytochemical; South-eastern Nigeria;
Introduction
Herbal plants by their high content of secondary metabolites are beneficial to man's health for the prevention and management of diseases/infections. The use of plant and/or plant products for the treatment of infections and as alternative medications is an age old custom in most of Nigerian homes [1-2]. Infections caused by resistant microorganisms are not responding to the standard treatment, resulting in prolonged illness, higher -health care expenditures and - risk of death [3-4]. Emerging resistance mechanisms are threatening our ability to treat common infectious diseases with consequences of death and higher medical cost.
The development and spread of antibiotic resistant strains of pathogenic bacteria as well as the occurrence of undesirable side effects of some antibiotics have heightened the interest on exploiting plant materials as alternatives to some conventional antibiotics [5]. The resistance problem therefore renewed efforts/ strategies in searching for antibacterial agents effective against pathogenic bacteria resistant to current antibiotics [5-6]. One of the strategies involves localization of plant bioactive phytochemicals [4]. Thus new prototype antimicrobial agents are needed and plants are among the most important common sources of potentially valuable new drugs.
Plants have an almost limitless ability to synthesize aromatic substances, which serve as plant defense mechanisms against predation by microorganisms, insects and herbivores. They are good natural sources of medications; provide raw materials for modern pharmaceuticals and are safe, less toxic and economical [4, 6-7]. Gongronema latifoliumis a tropical rainforest plant of the order Gentiales and the family Apocynaceae. It belongs to the Subfamily Asclepiadaceae, and genus Gongronema [8]. In South-eastern Nigeria, the Igbos call it “Utazi” and it is utilized for its medicinal and culinary properties as spice and vegetable for sauces and soups [8-9].
It has been reported that Gongronema latifoliumhasan antimicrobial activity against some species of microorganisms [9-10].In traditional medicine,Gongronema latifolium are used for the treatment of different bacterial infections such as the use in the treatment of stomach pains/infections. Therefore, this study was carried out to evaluate the antibacterial activity of the ethanolic leaf extract of Gongronema latifoliumon multidrug resistant (MDR) clinical bacterial isolates.
Materials and Methods
Mueller-Hinton Agar was procured from Biomark Laboratory (India), Mannitol Salt Agar, MacConkey Agar, Nutrient Agar and Nutrient Broth (All procured from Titan Biotech. Ltd; India), Peptone Water (HiMedia Labs. Ltd; Mumbai, India) while Antibiotic Sensitivity disc was from Oxoid ltd. (England).
Collection and identification of plant materials
The leaves of the plant, Gongronema latifolium were bought from Eke-ututu market of Orsu-Ihiteukwa in Orsu Local Government Area of Imo state, Nigeria. The plant was identified and authenticated by a botanist Mr. Alfred Ozioko of University of Nigeria Nsukka and the Herbarium specimen deposited in the Pharmacognosy Department of Nnmadi Azikiwe University, Awka. The plant samples were washed using water and air-dried and then ground into uniform powder using Thomas Willey milling machine.
The leaves of the plant, Gongronema latifolium were bought from Eke-ututu market of Orsu-Ihiteukwa in Orsu Local Government Area of Imo state, Nigeria. The plant was identified and authenticated by a botanist Mr. Alfred Ozioko of University of Nigeria Nsukka and the Herbarium specimen deposited in the Pharmacognosy Department of Nnmadi Azikiwe University, Awka. The plant samples were washed using water and air-dried and then ground into uniform powder using Thomas Willey milling machine.
Preparation of the plant extract
Two hundred grams (200g) of the leaves of the plant was cold macerated with one liter of absolute ethanol in two separate maceration container containing 100g per 500 mL each for 48 hours. At the end of the extraction, the suspension was filtered with Whatman filter paper No. 1 (Whatman, Maidstone, England) and the filtrate was dried in a hot air oven regulated at 500C (AMPUL dryer) and the dried filtrates was stored in the fridge at 4oC for further use.
Two hundred grams (200g) of the leaves of the plant was cold macerated with one liter of absolute ethanol in two separate maceration container containing 100g per 500 mL each for 48 hours. At the end of the extraction, the suspension was filtered with Whatman filter paper No. 1 (Whatman, Maidstone, England) and the filtrate was dried in a hot air oven regulated at 500C (AMPUL dryer) and the dried filtrates was stored in the fridge at 4oC for further use.
Study Area
The urine, stool and wound samples were collected from both inpatients and outpatients of the Chukwuemeka Odimegwu Ojukwu University Teaching Hospital, (COOUTH) Awka, whereas the orthopaedic wound samples were collected from Orthopaedic hospital Enugu. This sample collection sites were chosen because they covers the urban area of the city of Anambra and Enugu (South-eastern Nigerian states) respectively where high population of individuals /referrals with varieties of infections are found. The study protocol was approved by the ethical committee of Chukwuemeke Odumegwu Ojukwu University Teaching Hospital (COOUTH) Awka (Refs: COOUTH/AA/VOI.I.002& VOI.I.008).
The urine, stool and wound samples were collected from both inpatients and outpatients of the Chukwuemeka Odimegwu Ojukwu University Teaching Hospital, (COOUTH) Awka, whereas the orthopaedic wound samples were collected from Orthopaedic hospital Enugu. This sample collection sites were chosen because they covers the urban area of the city of Anambra and Enugu (South-eastern Nigerian states) respectively where high population of individuals /referrals with varieties of infections are found. The study protocol was approved by the ethical committee of Chukwuemeke Odumegwu Ojukwu University Teaching Hospital (COOUTH) Awka (Refs: COOUTH/AA/VOI.I.002& VOI.I.008).
The duration of the study was 5 months (January to May 2016). The study was carried out in the Microbiology Laboratory of the Department of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Agulu Campus.
Study Population
Various clinical samples (urine, stool and orthopaedic wound swabs) of patients comprising of both male and female patients both inpatients outpatients were collected after their informed consent was obtained.
Various clinical samples (urine, stool and orthopaedic wound swabs) of patients comprising of both male and female patients both inpatients outpatients were collected after their informed consent was obtained.
Identification and Characterization of Isolates
Identification of bacterial isolates was done on the basis of their cultural, microscopic and biochemical characteristics [11].
Identification of bacterial isolates was done on the basis of their cultural, microscopic and biochemical characteristics [11].
Antibiotic Susceptibility Testing and detection of multidrug resistance isolates
Antibiotic susceptibility of pure cultures of confirmed isolates was performed on Mueller Hinton Agar by the standard Kirby Bauer disc diffusion method as described elsewhere [12]. The following antibiotics were tested : Levofloxacin (LEV) 5 µg, Ceftriaxone (CEF) 30 µg, Gentamycin (GEN) 30 µg, Azithromycin (AZM) 15µg, Penicillin (P) 10UNIT, Nitrofurantoin (NIT) 300 µg, Amoxicillin/Clavulanate (AMC) 30 µg.
Antibiotic susceptibility of pure cultures of confirmed isolates was performed on Mueller Hinton Agar by the standard Kirby Bauer disc diffusion method as described elsewhere [12]. The following antibiotics were tested : Levofloxacin (LEV) 5 µg, Ceftriaxone (CEF) 30 µg, Gentamycin (GEN) 30 µg, Azithromycin (AZM) 15µg, Penicillin (P) 10UNIT, Nitrofurantoin (NIT) 300 µg, Amoxicillin/Clavulanate (AMC) 30 µg.
The Inhibition Zone Diameter in millimeter (IZD in mm) produced were interpreted using the European Committee on Antimicrobial Susceptibility Testing (EUCAST 2011) and British Society for Antimicrobial Chemotherapy (BSAC). After interpretation of the result, the organisms that were resistance to at least four (4) of the antibiotics used were considered multidrug resistant (MDR) and were selected for further evaluation of the antibacterial activities of the plant extracts.
Phytochemical Screening
Photochemical tests were carried out on the ethanolic extract and on the powdered specimens using standard procedures to identify the constituents [5].
Photochemical tests were carried out on the ethanolic extract and on the powdered specimens using standard procedures to identify the constituents [5].
Determination of antibacterial activity of the plant extract
Agar well diffusion method as described by Esimone., et al. [13] was used to determine the antibacterial activity of the extract. Briefly, 800 mg/mL concentration of the ethanolic extracts was prepared by dissolving 1.6g of the extract in 2 mL of 10% DMSO and then a 2-fold serial dilution was done to obtain 400 mg/mL, 200 mg/mL, 100 mg/mL, 50 mg/mL, 25 mg/mL and 12.5 mg/mL concentrations for further use. Mueller Hinton agar was prepared according to the manufacturer’s instructions. Overnight broth cultures of the organisms were standardized to 0.5 MacFarland standard. With the aid of a sterile 1mL syringe, 1mL of the standardized suspension of the isolates was mixed with 19 mL of the agar in sterilized petri-dishes. The inoculated agar plates were allowed to solidify and the plates were properly labeled. A sterile cork borer was used to bore eight holes in the agar with a diameter of 7 mm.
Agar well diffusion method as described by Esimone., et al. [13] was used to determine the antibacterial activity of the extract. Briefly, 800 mg/mL concentration of the ethanolic extracts was prepared by dissolving 1.6g of the extract in 2 mL of 10% DMSO and then a 2-fold serial dilution was done to obtain 400 mg/mL, 200 mg/mL, 100 mg/mL, 50 mg/mL, 25 mg/mL and 12.5 mg/mL concentrations for further use. Mueller Hinton agar was prepared according to the manufacturer’s instructions. Overnight broth cultures of the organisms were standardized to 0.5 MacFarland standard. With the aid of a sterile 1mL syringe, 1mL of the standardized suspension of the isolates was mixed with 19 mL of the agar in sterilized petri-dishes. The inoculated agar plates were allowed to solidify and the plates were properly labeled. A sterile cork borer was used to bore eight holes in the agar with a diameter of 7 mm.
Using a micropipette, 0.1 mL of the reconstituted plant extracts were delivered into seven of the labeled wells; and 0.1 mL of a 10 µg/mL Gentamicin solution (Gentalek, India) was used as a positive control in the 8th hole. The plates were left for 30 minutes at room temperature to allow the extracts and the drug to diffuse into the agar. This was done in duplicates for each concentration of the extract against the three microorganisms used. The plates were incubated at 37°C for 24 hrs. After incubation, the plates were observed for inhibition zones around the wells. The diameters were measured and the mean inhibition zone diameter (IZD) was recorded to the nearest whole millimeter.
Determination of the minimum inhibitory concentration (MIC)
The MIC was determined using Agar dilution method as described by the European Committee for Antimicrobial Susceptibility Testing (EUCAST) [14]. An 800 mg of the extract was weighed using a sensitive balance and reconstituted in 4 mL of 10% DMSO to obtain a concentration of 200 mg/mL. A two-fold serial dilution was made to obtain concentrations of 100 mg/mL, 50 mg/mL, 25 mg/mL, 12.5 mg/mL, 6.25 mg/mL and 3.125 mg/mL. A 19 mL of the molten Muller-Hinton agar was mixed with 1 mL of the plant extract dilutions in sterile Petri dishes and labelled accurately.
The MIC was determined using Agar dilution method as described by the European Committee for Antimicrobial Susceptibility Testing (EUCAST) [14]. An 800 mg of the extract was weighed using a sensitive balance and reconstituted in 4 mL of 10% DMSO to obtain a concentration of 200 mg/mL. A two-fold serial dilution was made to obtain concentrations of 100 mg/mL, 50 mg/mL, 25 mg/mL, 12.5 mg/mL, 6.25 mg/mL and 3.125 mg/mL. A 19 mL of the molten Muller-Hinton agar was mixed with 1 mL of the plant extract dilutions in sterile Petri dishes and labelled accurately.
The mixture was allowed to solidify and a sterile wire loop was used to streak a loopful of the standardized inoculum on the surface of the dried agar. The plates were then incubated at 37°C for 24 hrs, after which the plates were observed for the presence of turbidity. The lowest dilution showing no turbidity was recorded as the MIC. A control experiment was run in parallel to study the impact of the solvent (i.e. DMSO) on the growth of the tested organism. The tests were done in duplicate against MDR E. coli, K. pneumoniae S. aureus and S. saprophyticusand the mean MIC was recorded to the nearest whole concentration.
Determination of Minimum Bactericidal Concentration (MBC)
This was done as an extension of the MIC assay as the agar plates showing no growth of visible colonies in the MIC evaluation were used to determine the MBC. The plates were further incubated at 37°C for 72 hours. The lowest concentrations showing no turbidity were recorded as the MBC for the different organisms.
This was done as an extension of the MIC assay as the agar plates showing no growth of visible colonies in the MIC evaluation were used to determine the MBC. The plates were further incubated at 37°C for 72 hours. The lowest concentrations showing no turbidity were recorded as the MBC for the different organisms.
Results and Discussion
The increasing incidence of antibiotic-resistant pathogens has drawn the attention of the pharmaceutical/ scientific communities towards research on the potential antimicrobial activity of plant-derived substances [5,15]. This study is designed to evaluate the antibacterial effects of G. latifolium (UTAZI) on multidrug resistant clinical bacterial isolates. A high degree of resistance of the bacterial isolates to multiple classes of antibiotics used was noted. Almost all the antibiotics proved less effective against all tested bacteria isolated from clinical samples.
Table 1 shows the results of the antibiotic resistance profile of the bacterial isolates. It revealed that most of the isolated bacteria were found to be resistant to the conventionally used antibiotics. All the bacterial isolates were highly resistant (60-100%) to Azithromycin, Penicillin, nitrofurantion, levofloxacin and penicillin. They all had good/moderate sensitivity to Amoxicillin – clavualnic acid as against penicillin and Ceftriaxone. This may be due to presence of clavulanic acid in the combination that expectedly should protect the Amoxicillin component against the activities of β-lactamases and increased indiscriminate and/or unregulated use of the β-lactam antibiotics in the studied area leading to emergence of antibiotic resistant bacteria with consequent emergence of β-lactamases [16].
Isolates | AMC | GEN | LEV | NIT | PCN | AZM | CEF | ||||||||||||||
S | MS | R | S | MS | R | S | MS | R | S | MS | R | S | MS | R | S | MS | R | S | MS | R | |
S. aureus | 71.4 | 0 | 28.6 | 4.8 | 4.8 | 90.4 | 14.3 | - | 85.7 | 5 | - | 95 | 0 | 0 | 100 | 7.3 | 4.9 | 87.8 | 0 | 0 | 100 |
E. coli | 30 | 20 | 50 | 0 | 10 | 90 | 20 | 20 | 60 | 20 | - | 80 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 |
K. pneumoniae | 10 | 40 | 50 | 5 | 0 | 95 | 30 | 10 | 60 | 20 | - | 80 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 |
S.saprophyticus | 60 | 0 | 40 | 5 | 0 | 95 | 0 | 5 | 95 | 5 | - | 95 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 0 | 100 |
Table 1: Antibogram of the Bacterial Isolates.
KEY: AMC = Amoxicillin-clavulanic acid, GEN = Gentamicin LEV = Levofloxacin PCN = Penicillin AZM = Azithromycin, CEF = Ceftriaxpne S = % Susceptible R= % Resistant MS = %Moderately sensitive
KEY: AMC = Amoxicillin-clavulanic acid, GEN = Gentamicin LEV = Levofloxacin PCN = Penicillin AZM = Azithromycin, CEF = Ceftriaxpne S = % Susceptible R= % Resistant MS = %Moderately sensitive
Antibiotics resistance occurs when antibiotics are over prescribed or misused [17-18]. It is this kind of MDR scenario or risk factors in the development of resistance amongst clinically important pathogens that necessitates development and search for novel sources (e.g. plants) of antimicrobial agents. The phytochemical analysis of the plant extract (Table 2) showed that ethanolic leaf extract of G.latifolium contain some phytoconstituents such as saponins, tannins, flavonoids, alkaloids, cardiac glycosides, proteins, steroids with no trace of terpenoids and these constituents can be associated with some of the beneficial antibacterial effects of the plant as shown in Tables 3-6.
S/No | Phytochemical test | Plant Extract |
1 | Alkaloid | + |
2 | Saponins | +++ |
3 | Tannins | +++ |
4 | Flavonoid | ++ |
5 | Steroid | +++ |
6 | Terpenoid | _ |
7 | Cardiac Glycoside | + |
8 | Protein | + |
Table 2: The photochemical screening of the plant extract.
+ = mildly present, ++ = moderately present, +++ = abundantly present, - = absent.
+ = mildly present, ++ = moderately present, +++ = abundantly present, - = absent.
The antibacterial activities of the ethanolic leaf extract of Gongronema latifolium Benth on MDR bacterial isolates was evaluated in terms of IZD, MIC and MBC. The ethanolic leaf extract of G. latifoliumas observed from this work, have concentration dependent inhibitory effect on the MDR test organisms E. coli, S. aureus, S. saprophyticus and K. pneumoniae(Tables 3-6). The inhibition zone diameter ranged from 2.0-8.5 mm for MDRE. coli, S. aureus and S. saprophyticus and 2.0-9.5 mm for MDR K. pneumonia.
Inhibition zone diameter (mm) | |||||||||
Isolates | 400 mg/mL | 200 mg/mL | 100 mg/mL | 50 mg/mL | 25 mg/mL | 12.5 mg/mL | 6.25 mg/mL | Positive control | |
K1 | 8.5 | 6.5 | 5 | 4.5 | 5 | 5 | 5.5 | 0 | |
K2 | 6.5 | 7 | 6 | 6 | 6 | 3.5 | 4.5 | 10 | |
K3 | 6.5 | 7.5 | 4 | 5 | 3 | 2.5 | 2 | 11.5 | |
K4 | 6.5 | 7 | 6 | 4 | 4 | 4 | 3 | 0 | |
K5 | 7 | 5.5 | 5 | 3 | 4.5 | 4.5 | 3.5 | 6 | |
K6 | 7.5 | 6.5 | 6 | 5 | 5.5 | 4.5 | 7 | 0 |
Table 3: The Inhibition Zone Diameter of the Plant Extract against K. pneumoniae.
Inhibition zone diameter (mm) | ||||||||
Isolates | 400 mg/mL | 200 mg/mL | 100 mg/mL | 50 mg/mL | 25 mg/mL | 12.5 mg/mL | 6.25 mg/mL | Positive control |
E1 | 7 | 5 | 5 | 3.5 | 3.5 | 3 | 2 | 10 |
E2 | 8 | 6 | 5 | 4.5 | 4.5 | 4.5 | 6 | 0 |
E3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
E4 | 6.5 | 6.5 | 6 | 5 | 2 | 3 | 4 | 0 |
E5 | 8.5 | 7.5 | 5.5 | 4.5 | 4 | 3 | 2.5 | 0 |
E6 | 8.5 | 8 | 6 | 4.5 | 2.5 | 2.5 | 0 | 13.5 |
E7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
E8 | 7.5 | 7 | 7.5 | 4 | 0 | 0 | 0 | 8 |
E9 | 8 | 7.5 | 7.5 | 5.5 | 2.5 | 3 | 3 | 8 |
Table 4: The Inhibition Zone Diameter of the Plant Extract against E. coli.
Inhibition zone diameter (mm) | ||||||||
Isolates | 400 mg/mL | 200 mg/mL | 100 mg/mL | 50 mg/mL | 25 mg/mL | 12.5 mg/mL | 6.25 mg/mL | Positive Control |
S1 | 7 | 7.5 | 6 | 5 | 3.5 | 0 | 0 | 0 |
S2 | 7.5 | 5.6 | 5.5 | 4.5 | 4 | 3.5 | 3 | 4.5 |
S3 | 8.5 | 7 | 7 | 4 | 3.5 | 3.5 | 2 | 9 |
S4 | 4.5 | 4 | 4.5 | 0 | 0 | 0 | 0 | 0 |
S5 | 7.5 | 6.5 | 5 | 2.5 | 0 | 0 | 0 | 0 |
S6 | 7 | 6.5 | 3.5 | 3.5 | 4 | 4.5 | 2.5 | 0 |
S7 | 8 | 7 | 6.5 | 5.5 | 3.5 | 3.5 | 2 | 10.5 |
S8 | 7.5 | 8.5 | 4 | 5 | 2.5 | 3 | 2 | 6.5 |
S9 | 7.5 | 6.5 | 6 | 5 | 4.5 | 4 | 3.5 | 8.5 |
S10 | 8.5 | 7.5 | 4.5 | 3.5 | 3.5 | 4 | 3.5 | 5 |
Table 5: The Inhibition Zone Diameter Of The Plant Extract Against S.aureus.
Inhibition zone diameter (mm) | ||||||||
Isolates | 400 mg/mL | 200 mg/mL | 100 mg/mL | 50 mg/mL | 25 mg/mL | 12.5 mg/mL | 6.25 mg/mL | Positive Control |
Ss1 | 9.5 | 7 | 5.5 | 3 | 3.5 | 3 | 3 | 3 |
Ss2 | 7.5 | 7 | 4.5 | 3 | 3.5 | 2.5 | 3 | 12.5 |
Ss3 | 8 | 7.5 | 3.5 | 4 | 4 | 3 | 2 | 5.5 |
Ss4 | 7 | 6 | 7 | 5 | 4.5 | 3 | 3 | 5 |
Ss5 | 7 | 6 | 6 | 5 | 5 | 4 | 3.5 | 9 |
Ss6 | 8 | 7 | 6.5 | 6 | 5.5 | 4.5 | 3.5 | 5.5 |
Ss7 | 6 | 5 | 4 | 3.5 | 4 | 4 | 3 | 9 |
Ss8 | 7 | 6.5 | 5.5 | 5.5 | 4.5 | 3.5 | 3 | 8 |
Ss9 | 7.5 | 6 | 6 | 5.5 | 5 | 4.5 | 3 | 6.5 |
Table 6: The Inhibition Zone Diameter of the Plant Extract against S. saprophyticus.
The Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of the plant extract against the bacterial isolates is shown in Table 7. The MIC of the extract against K. pneumoniae isolates ranged from 0.3125-1.25 mg/ml and MBC range from 0.625-2.5 mg/ml, for Escherichia coli isolates the MIC of the extract ranged from 0.3125-2.5 mg/ml and MBC range from 1.25-2.5 mg/ml. The Minimum Bactericidal Concentration (MBC) of the plant extract against the S. aureus ranges from 0.625-2.5 mg, The Minimum Inhibitory Concentration (MIC) of the plant extract against the S. saprophyticusranges from 0.625-2.5 mg and the MBCranges from 1.25-10 mg.
Concentration (mg/ml) | ||||||||
S. aureus | K. pneumoniae | E. coli | S. saprophyticus | |||||
Isolates | MIC | MBC | MIC | MBC | MIC | MBC | MIC | MBC |
1 | 0.625 | 0.625 | 0.3125 | 1.25 | 1.25 | 2.5 | 1.25 | 2.5 |
2 | 0.625 | 1.25 | 0.3125 | 0.625 | 0.3125 | 1.25 | 2.5 | 10 |
3 | 1.25 | 2.5 | 0.625 | 2.5 | 1.25 | 2.5 | 0.625 | 2.5 |
4 | 1.25 | 1.25 | 1.25 | 1.25 | 2.5 | 2.5 | 2.5 | 2.5 |
5 | 1.25 | 2.5 | 0.625 | 1.25 | 1.25 | 2.5 | 1.25 | 1.25 |
Table 7: The Minimum Inhibitory Concentration (Mic) And Minimum Bactericidal.
Phytochemical analyses of different parts of G. latifoliumhave shown that the plant is rich in quite a good number of phytochemicals. The Phytochemical studies of the G. latifolium have shown that the antibacterial properties of these plants depend on certain active ingredients: saponins, tannins, steroids , flavonoids etc [19]. G. latifolium contain saponins and these have been known to be responsible for its antioxidant and antimicrobial properties [20-21]. The phytochemicals reported in this study have been documented for various antibacterial properties [22-23].
Flavonoids are known to have antiseptic and antibacterial properties, inhibitory to S. aureusand have been used in treatment of inflamed tissues [24]. Saponins also have been reported to be produced by plants to stop bacterial and fungal attacks, making them natural source of antimicrobials [22,25]. The rich amount of secondary metabolites in the leaf extract can explain why the ethanolic extracts of leaf exhibited good inhibitory effects on the MDR organisms. Aqueous and methanol leaf extracts of G. latifolium were reported to have exhibited antibacterial effects on a number of bacteria including E. coli and S. aureus [26]. Omodamiro and Ekeleme, [27] also reported that the ethanolic leaf extract showed a significant dose dependent inhibition of S. aureus, S. pneumoniae, E. coli, Proteus mirabilis and Pseudomonas aeruginosa.
Conclusively this study reports that the ethanolic leaf extract of Gongronema latifolium Benth, has activity against multiple drug resistant bacterial isolates. The order of activity against the multiple drug resistant strain was K. pneumoniae > E. coli > S. aureus > and S. saprohyticus. Therefore the ethanolic leaf extract of G. latifoliumcan be effectively used in the eradication/treatment of clinical infections caused by the multiple drug resistance isolates of K. pneumoniae, E. coli, S. aureus and S. saprophyticus. Antibacterial effect of G. latifolium which is evident from this study explains the long history of the use of these plants in traditional medicine for the treatment of different bacterial infections such as the use in the treatment of stomach pains/infections.
References
- Ejikeugwu C., et al. “Evaluation of antibacterial activity of the leave extracts of Buchholzia coriacea”. Asian journal of pharmaceutical and biological research 2.4 (2012): 204-209.
- Ejikeugwu C., et al. “Phytochemical and antibacterial screening of crude extracts from leaves of wonderful kola”. American Journal of Life Sciences 2.6-3 (2014): 9-12.
- Golkar Z., et al. “Bacteriophage therapy: a potential solution for the antibiotic resistance crisis”. The Journal of Infection in Developing Countries 8.2 (2014):129–136.
- Pratiwi W, Elin YS. “The antibacterial activity of selected plants towards resistant bacteria isolated from Clinical specimens”. Asian Pacific Journal of Tropical Biomedicine 6.1 (2016): 16–19.
- Enemor EC., et al. “Phytochemical analysis and Antimicrobial Activity of Ethanolic Stem Extracts of Cnestis ferruginea on Multidrug Resistant Bacteria Isolated from Raw Retail Meat Sold in Awka, Nigeria”. Journal of Pharmaceutical Sciences and Research 7.11(2015): 1044-1049.
- Deepti R., et al. “Phytochemical screening and antimicrobial activity of Picrorrhiza kurroa, an Indian traditional plant used to treat chronic diarrhea”. Arabian Journal of Chemistry 9 (2016): 1307–1313.
- Sooad A., et al. “Antibacterial activity and phytochemical screening of some medicinal plants commonly used in Saudi Arabia against selected pathogenic microorganisms”. Journal of King Saud University – Science 25.2 (2013): 115–120.
- Osuagwu AN., et al. “The Biology, Utilization and Phytochemical Composition of the fruits and leaves of Gongronema latifolium Benth”. Agro technology 2(2013): 115.
- Enyi-Idoh KH., et al. “In Vivo Studies of Antibacterial Activity of Gongronema latifolium and Antibiotics on Staphylococcus aureus Infected Albino Rats”. International Journal of Current Microbiology and Applied Sciences6.1 (2017): 811-818.
- Enyi-Idoh KH., et al. “Time-Dependent evaluation of the antibacterial and phytochemical properties of Vernonia amygdalina and Gongronema latifolium”. The Internet Journal of Herbal and Plant Medicine1.2 (2012): 1-11.
- Cheesbrough M. “District laboratory practice in tropical countries”. Cambridge 374 University Press UK (2004): 136-42.
- Ike B., et al. “Prevalence, Antibiogram and Molecular Characterization of Comunity-Acquired Methicillin-Resistant Staphylococcus Aureus in AWKA, Anambra Nigeria”. The Open Microbiology Journal 10 (2016): 211-221.
- Esimone CO., et al. “Preliminary Antimicrobial Screening of the Ethanolic extract from the lichen Usneasubfloridans L”. International Journal of Research and Developement 3 (1998): 99-102.
- European Committee on Antimicrobial Susceptibility Testing (2011):
- Gamil SG., et al. “Antimicrobial Effect of Honey and Some Herbal Plant Extracts Against Multidrug Resistance Bacteria Isolated from Patient in Local Riyadh Hospital”. International Journal of Advanced Research 4.4 (2016): 283-291.
- Ejikeugwu PC., et al. “Imipenem and meropenem resistance amongst ESBL producing Escherichia coli and Klebsiella pneumonia clinical isolates”. International Research Journal of Microbiology 3.10 (2012): 339-344.
- Ejikeugwu C., et al. “Phenotypic Screening of Clinical Isolates of Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa for Metallo-Beta-Lactamase”. Life Sciences – Journal 13.10 (2016): 77-83.
- Ejikeugwu C., et al. “Phenotypic Detection of AmpC Beta-Lactamase among Anal Pseudomonas aeruginosa Isolates in a Nigerian Abattoir”. Archives of Clinical Microbiology 7.2 (2016): 1-5.
- Nwinyi OC., et al. “Evaluation of antibacterial activity of Pisidum guajava and Gongronema latifolium”. Journal of Medicinal Plants Research 2 (2008): 189-192.
- Morebise O., et al. “Biochemical studies on the activity of Gongronema latifolium leaves in experimental arthritis”. International Journal of Biomedical and Healthcare Science 1.2 (2005): 71-76.
- Morebise O., et al. “Antiinflammatory property of Gongronema latifolium”. Phytotherapy Research 16 (2012): S75-S77.
- Ajani EO., et al. “Evaluation of the Acute and Sub-acute Toxicity Effects of Ethanolic Leaves Extract of Lagenaria brevifolia (Bitter gourd) on Hepatic and Renal Function of Rats”. European Journal of Medicinal Plants5.2 (2015): 210-219.
- Balogun ME., et al. “Gongronema Latifolium: A Phytochemical, Nutritional and Pharmacological Review”. Journal of Physiology and Pharmacology Advances 6.1 (2016): 811-824.
- Kar A. “Pharmacognosy and Pharmacobiotechnology (Revised- Expanded Second Edition)”. New Age International Limited Publishers, New Delhi (2007): 332-600.
- Okwu DE and Emenike IN. “Evaluation of the phytonutrients and vitamin contents of citrus fruits”. International Journal of Molecular Medicine and Advance Sciences 2.1(2006): 1–6.
- Eleyinmi AF. “Chemical composition and antibacterial activity of Gongronema latifolium”. Journal of Zhejiang University SCIENCE 8.5 (2007): 352-358.
- Omodamiro OD and Ekeleme CM. “Comparative study of invitro antioxidant and antimicrobical activities of Piper guineense, Curmuma longa, Gongronema latifolium, Allium sativum, Ocimum gratissimum”. World Journal of Medicine and Medical Science 1.4 (2013): 51-69.
Citation:
Malachy C Ugwu., et al. “Antibacterial Evaluation of Ethanolic Leaf Extract of Gongronema Latifolium Benth on MDR Bacteria
from Clinical Specimens”. Clinical Biotechnology and Microbiology 1.4 (2017): 156-164.
Copyright: © 2017 Malachy C Ugwu., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.